> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Erectile Dysfunction Drug Notice Sought
- URL: https://www.fdaweb.com/erectile-dysfunction-drug-notice-sought/
- Published: 2020-02-11T12:00:00.000Z
- Updated: 2026-09-14T16:02:29.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5146064

The Physicians Committee for Responsible Medicine says FDA should require that all product packaging and labeling for erectile dysfunction drugs disclose information on the role of cardiovascular disease in erectile dysfunction and the role of diet and lifestyle in cardiovascular health.

The committee’s [petition](https://www.regulations.gov/contentStreamer?documentId=FDA-2020-P-0698-0001&attachmentNumber=1&contentType=pdf&ref=fdaweb.com) suggests wording that should be used and says that “to ensure that physicians and patients understand the health risks, including the risk for early mortality, associated with erectile dysfunction, as well as basic lifestyle and diet steps that can address those risks without medication, the commissioner should require erectile dysfunction drug manufacturers to prominently place the … notice on all product packaging and labeling.”

The suggested statement reads: erectile dysfunction is caused by artery disease, a condition that this drug will not improve. Artery disease can lead to heart attacks, strokes, and early death. A plant-based diet, moderate exercise, stress management, and lack of smoking can, in combination, improve and often reverse artery disease.